Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meng-Xuan Zhu
Observed names:
Mengxuan Zhu,
Zhu Mengxuan
Institutions:
Shanghai Medical College of Fudan University,
Chengde Medical University,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Chengde Medical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Zhongshan Hospital
ORCID:
0000-0003-0925-670X
Observed ORCID:
0000-0003-0925-670X
OpenAlex ID:
A5103030706
Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma
2019
·
Chuan-Yuan Wei
, Meng-Xuan Zhu
, et al.
·
Journal of Hematology & Oncology
·
182
PDF
PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma
2022
·
Chuan-Yuan Wei
, Meng-Xuan Zhu
, et al.
·
Journal of Hepatology
·
165
PDF
Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma
2020
·
Chuan-Yuan Wei
, Meng-Xuan Zhu
, et al.
·
Molecular Cancer
·
162
PDF
Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma
2018
·
Chuan-Yuan Wei
, Meng-Xuan Zhu
, et al.
·
Oncogene
·
81
PDF
TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4
2019
·
Chuan-Yuan Wei
, Lu Wang
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
74
PDF
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages
2024
·
Jiayu Zhang
, Yu Dong
, et al.
·
Cell Death and Disease
·
60
PDF
Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer
2022
·
Mengxuan Zhu
, Pengfei Zhang
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
53
PDF
Circular RNA drives resistance to anti-PD-1 immunotherapy by regulating the miR-30a-5p/SOX4 axis in non-small cell lung cancer
2022
·
Jing Wu
, Meng-Xuan Zhu
, et al.
·
Cancer Drug Resistance
·
34
PDF
Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer
2021
·
Xiao-Bo Ma
, Yuan-Yuan Xu
, et al.
·
Frontiers in Oncology
·
33
PDF
Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma
2019
·
Chuan-Yuan Wei
, Meng-Xuan Zhu
, et al.
·
Aging
·
18
PDF
Flavonoids: a natural remedy in the prevention and management of diverse diseases
2025
·
Bo Yu
, Jin Zhang
, et al.
·
Frontiers in Medicine
·
17
PDF
TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma
2022
·
Wang Lu
, Zhu Mengxuan
, et al.
·
Journal of Oncology
·
15
PDF
Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R‐Loop Accumulation and DNA Repair Deficiencies
2025
·
Chi Zhang
, Yanjing Zhu
, et al.
·
Advanced Science
·
10
Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
2019
·
Meng-Xuan Zhu
, Chuan-Yuan Wei
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
10
PDF
Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab
2023
·
Yi-Chou Wei
, Jiang-Yi Zhu
, et al.
·
Journal of Gastrointestinal Oncology
·
2
PDF
Elevated TRIP13 Drives the AKT/mTOR Pathway to Induce the Progression of Hepatocellular Carcinoma via Interacting with ACTN4
2019
·
Meng-Xuan Zhu
, Chuan-Yuan Wei
, et al.
·
SSRN Electronic Journal
·
2
Profiling genomic characteristics related to immunotherapy for gastric cancer with amplified MET.
2021
·
Yiyi Yu
, Wei Li
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
17
Citation count:
918
H-index:
12
I10-index:
14
Year
Topic
Type